期刊文献+

应用磁共振波谱分析和弥散张量成像鉴别颅内良、恶性肿瘤 被引量:5

Proton MR spectroscopy and diffusion tensor imaging to identify benign from malignant intracranial tumor: report of 33 cases
下载PDF
导出
摘要 目的研究氢质子磁共振波谱(protonmagnetic resonance spectroscopy,lH-MRS)和弥散张量成像(diffusion tensor imaging,DTI)对颅内良、恶性肿瘤鉴别诊断的价值。方法经病理证实的颅内肿瘤33例,其中包括脑膜瘤10例,听神经瘤4例,血管母细胞瘤1例,混合性胶质神经元肿瘤1例,胶质瘤11例,转移瘤5例,原始神经外胚层肿瘤1例。根据病理结果,将颅内肿瘤分为良性组(19例)和恶性组(14例)进行观察分析。所有患者均进行常规MRI和DTI扫描,22例行lH-MRS分析。lH-MRS感兴趣区包括肿瘤组织和瘤周组织,分别观察各个区域的胆碱(choline,Cho)、N-乙酰天冬氨酸(N-acetyla spartate,NAA)、肌酸(creatine,Cr)、脂质(lipid,Lip)和乳酸(lactate,Lac)峰,并比较Cho/NAA、Cho/Cr、NAA/Cr值和Lip、Lac峰值。测量肿瘤实质区、坏死囊变区、周边水肿区、水肿周边正常白质区和对侧白质区感兴趣区的平均弥散系数(meandiffusivity,MD)、各向异性(fractionalanisotropy,FA)值。结果良、恶性肿瘤在1H-MRS代谢图上都表现为Cho峰升高、NAA峰降低,良性肿瘤实质区Cho/NAA和Cho/Cr值均显著低于恶性肿瘤,差异具有统计学意义(P<0.01)。虽然良性肿瘤NAA/Cr值高于恶性肿瘤组,但差异无统计学意义(P>0.05)。13例良性肿瘤中8例检测到Lac峰,2例检测到低Lip峰。9例恶性肿瘤中7例检测到Lac峰,5例检测到Lip峰;良性肿瘤实质部分和瘤周正常白质区FA值明显高于恶性肿瘤,且差异具有统计学意义(P<0.05),而2组肿瘤间坏死囊变部分和瘤周水肿区FA值比较无显著差异(P>0.05)。良性肿瘤水肿周边正常白质区FA值明显高于对侧相应部位脑白质,且有统计学差异(P<0.05);恶性肿瘤水肿周边白质FA值虽低于对侧脑白质,但差异不显著(P>0.05);MD值在良性肿瘤实质部分显著高于恶性肿瘤(P<0.05),但在坏死囊变区、水肿区和周边正常白质区差异均无统计学意义(P>0.05);肿瘤实质部分MD值和FA值均与Cho/Cr呈线性负相关。结论1H-MRS能无创地分析颅内肿瘤代谢信息,Cho/NAA和Cho/Cr有助于肿瘤良、恶性的鉴别;Cho/Cr与MD、FA值呈负性相关,Cho/NAA与Cho/Cr值和FA、MD值可以有效的鉴别颅内良、恶性肿瘤。 Objective To investigate the value of proton MR spectroscopy ( ^1H-MRS) and diffusion tensor imaging in differentiating benign from malignant intracranial tumors. Methods Thirty-three patients with pathological confirmed brain tumor,including 10 meningiomas,4 acoustic neuromas,1 hemangioblastoma,1 mixed glioneuronal tumor,11 gliomas,5 metastasis and 1 primitive neuroectodermal tumor underwent conventional MRI and diffusion tensor imaging,and 22 of them performed proton magnetic resonance spectroscopy in our hospital from September to December 2008. Choine ( Cho) ,Nacetylaspartate ( NAA) ,creatine ( Cr) ,lipid ( Lip) and lactate ( Lac) level were measured in the tumor masses and peritumor tissues. Mean diffusivity ( MD) and fractional anisotropy ( FA) was obtained in solid area,necrosis area,peritumor edema area,white matter surrounding the edema and contralateral white matter. Results All the patients were divided into benign ( n = 19) and malignant ( n = 14) groups according to the pathological results. Both benign and malignant tumors showed low NAA and high Cho. The Cho/NAA and Cho/Cr value in solid area of the benign tumor was markedly lower than that of the malignant tumor,with a significant difference ( P〈0. 01) ,while the NAA/Cr ratio in the former group was higher than that of the later,though having no significant difference between them ( P〉0. 05) . Eight of 13 benign tumors had Lac peak,and 2 had Lip peak. Seven of 9 malignant tumors had Lac peak,and 5 had Lip peak. The FA value in solid area and white matter surrounding the edema of benign tumors was significant higher than that of the malignant ( P〈0. 05) ,however the difference of FA in the necrosis and peritumor edema area between the 2 groups was not significant ( P〉0. 05) . FA value in the white matter surrounding edema of benign tumor was significant higher than contralateral white matter ( P〈0. 05) . Although the FA value in the white matter surrounding edema of malignant tumor was lower than the contralateral white matter,though the difference didn't reach statistical significance ( P〉0. 05) . The difference of MD in solid area of benign and malignant tumor was significant ( P〈0. 05) ,but difference of necrosis, peritumor edema and white matter surrounding edema between the 2 groups was not significant ( P〉0. 05) . For the FA and MD value in solid part of tumor there was linear negative correlation with Cho/Cr ratio. Conclusion^1 H-MRS,a noninvasive technique for investigating the metabolic changes in brain tumor,is helpful to differentiate benign from malignant intracranial tumors through Cho/NAA and Cho/Cr ratios. There is negative correlation between Cho/Cr and FA,MD value. Cho/NAA,Cho/Cr and FA,MD value may effectively differentiate benign from malignant intracranial tumor.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第21期2061-2064,共4页 Journal of Third Military Medical University
基金 重庆市科技攻关项目(CSTC2007AC5014)~~
关键词 颅内肿瘤 磁共振波谱分析 弥散张量成像 代谢产物 鉴别诊断 intracranial tumor proton magnetic resonance spectroscopy diffusion tensor imaging metabolites differential diagnosis
  • 相关文献

参考文献12

  • 1杨本强,周丽娟,吴越,关长群.二维磁共振波谱分析在评价颅内胶质瘤中的临床应用[J].解剖科学进展,2007,13(3):239-243. 被引量:2
  • 2李志勇,徐海波,孔祥泉,刘定西,黄劲柏,孔祥闯,邹启贵.扩散张量成像对脑脓肿与坏死囊变性胶质瘤的鉴别诊断价值[J].临床放射学杂志,2007,26(12):1185-1188. 被引量:3
  • 3Bulakbasi N, Kocaogiu M, Ors F, et al. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors[ J].AJNR Am J Neuroradiol, 2003, 24(2) : 225 -233.
  • 4Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of muhivoxel 2D chemical-shift imaging proton MR spectroscopy, echop]anar perfusion and diffusion-weighted MRI[ J]. Neuroradiology, 2002, 44 ( 8 ) : 656 - 666.
  • 5Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging [ J ]. AJNR Am J Neuroradiol, 2003, 24(10) : 1989 -1998.
  • 6Di-Costanzo A, Scarabino T, Trojsi F, et al. Multiparametric 3T MR approach to the assessment of cerebral gliomas : tumor extent and malignancy[J]. Neuroradiology, 2006, 48(9) : 622 -631.
  • 7Bartha R, Megyesi J F, Wafting C J. Low-grade glioma: correlation of short echo time ^1H-MR spectroscopy with 23Na MR imaging [ J]. AJNR Am J Neuroradiol, 2008, 29 (3) : 464 -470.
  • 8Hoiodny A I, Ollenschlager M. Diffusion imaging in brain tumors[ J]. Neuroimaging Clin N Am, 2002, 12(1 ) : 107 -124, x.
  • 9张冬,廖翠薇,舒通胜,邹利光,王文献,孙清荣,戴书华,杨春燕.脑胶质瘤的磁共振弥散张量成像研究[J].第三军医大学学报,2008,30(16):1496-1498. 被引量:6
  • 10Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging[J]. Radiology, 2006, 240(3) : 803 -810.

二级参考文献30

  • 1张焱,张战利,程敬亮,高剑波,杨涛,李荫太,周志刚,任翠萍.脑膜病变31例MRI分析[J].郑州大学学报(医学版),2006,41(3):588-589. 被引量:1
  • 2王兆平.以椎体破坏为首发征象的恶性淋巴瘤CT、MRI表现及比较[J].实用临床医药杂志,2006,10(4):126-127. 被引量:2
  • 3Schwaighofer BW,Klein MV,Wesbey G,et al.Clinical experience with routine Gd-DTPA administration for MR imaging of the brain[J].J comput Assist Tomgr,1990,14:11-17.
  • 4Healy ME,Hesselink JR,Press GA,et al,Increased detection of intracranial metastasis with intravenous Gd-DTPA[J].Radiology,1987,165:619-624.
  • 5Castillo M,Kwock L,Mukherji SK.Clinical applications of proton MR spectroscopy[J].AJNR,1996,17:1-15.
  • 6Lenkinski RE,Schnall MD.MR spectroscopy and the biochemical basis of neurological disease.In:Atlas SW,ed.Magnetic resonance imaging of the brain and spine[M].New York:Raven,1991,1099-1121.
  • 7Meyerand,Pipas TM,Mamourian A,et al.Classification of biopsy-confirmed brain tumors using single-voxel.MR spectroscopy[J].AJNR,1999,20:117-123.
  • 8Singh AK,Wang AM,Sauders wet al,Proton MR spectroscopy of brain lesion[J].Radiologist,2003,10:31-37.
  • 9Leclerc X,Huisman TA,Sorensen AG.The potential of proton magnetic resonance spectroscopy(1H-MRS) in the diagnosis and management of patients with brain tumors[J].Curr opin Oncol,2002,14:292-298.
  • 10Rand SD,Prost R,Haughton V,et al.Acurracy of single-voxel proton MR spectroscopy distinguishing neoplastic from non-neoplastic lesions of brain[J].AJNR,1997,18:1695-1704.

共引文献8

同被引文献44

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部